Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

2

About John Kelly

John Kelly is the CTO at Symantec of Seattle.

John Kelly Headquarter Location

Seattle, Washington,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest John Kelly News

XIFIN Appoints John Kelly to Chief Information Officer

May 18, 2022

Former PatientKeeper and Cigna executive brings extensive technology leadership experience including customer-focused innovation and merging organizations for operational success Download John Kelly, chief information officer, XIFIN (Photo: Business Wire) May 18, 2022 09:00 AM Eastern Daylight Time SAN DIEGO--( BUSINESS WIRE )-- XIFIN announced today that John Kelly has joined the company as chief information officer. In this role, a first for the company, Kelly will advance product and service cohesion and operations as XIFIN integrates its recent corporate acquisitions and continues its growth trajectory. Kelly comes to XIFIN with more than 20 years of experience aligning organizations and creating innovative software solutions for healthcare companies and other B2B industries. Throughout his career, he has facilitated innovative solutions through organizational transformations, technology, processes, and mergers and acquisitions. “Our business is uniquely positioned to drive greater efficiencies for providers on the clinical and financial sides of the business through digital transformation,” said Lâle White, CEO. “John brings a holistic, systems-thinking approach that will help us improve our technological alignment to address evolving industry, organizational and patient needs, including increased demand for more convenient, cost-effective care settings. He will lead the continued streamlining of our technologies to deliver workflow solutions for pharmacies, diagnostic providers and payors that enhance patient care and engagement.” Kelly will report directly to CEO Lâle White and work alongside the executive and product leadership teams to advance XIFIN’s technology initiatives. His initial focus will be integrating technologies to realize synergies from recently acquired companies, including OmniSYS , a leading provider of solutions for the retail pharmacy industry. "XIFIN is going through a tremendous growth period, and I’m honored to help position the company for continued success,” said Kelly. “I pride myself on building flexible solutions that help organizations scale and pivot. I look forward to helping more healthcare organizations benefit from XIFIN’s powerful solutions — gaining greater insights from clinical and financial data, and ultimately providing optimal outcomes for patients.” Most recently, Kelly served as chief technology officer for PatientKeeper, working on the company’s EHR optimization software solution that focuses on clinician workflows. In this role, he was also responsible for migrating PatientKeeper’s on-premises and mobile products to cloud-native solutions. Previously, Kelly spent more than a decade with Cigna, where he served as chief technologist across multiple business units and developed the payor’s Affordable Care Act marketplace registries. XIFIN continues to expand its leadership board and this news follows the company’s recent announcement of Harley Ross's appointment to chief commercial officer. About XIFIN XIFIN is a healthcare information technology company that leverages diagnostic information to improve the quality and economics of healthcare. The company's cloud-based technology facilitates connectivity and workflow automation for accessing and sharing clinical and financial diagnostic data, linking healthcare stakeholders in the delivery and reimbursement of care across diagnostic, retail pharmacy and oncology markets. The company provides cross-specialty industry analytics including its Lab Volume Index which provides a measurement of laboratory testing volumes across the US. Its synthesis of diagnostic data enables comparisons of hospital, genetics, pathology, routine lab, COVID-19, and antibody testing across key segments. To learn more, visit www.XIFIN.com , follow XIFIN on Twitter and LinkedIn , or subscribe to the XIFIN blog . Contacts

John Kelly Investments

2 Investments

John Kelly has made 2 investments. Their latest investment was in Orion Labs as part of their Series A - IV on September 9, 2017.

CBI Logo

John Kelly Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/6/2017

Series A - IV

Orion Labs

$10.5M

Yes

3

10/14/2010

Angel

Subscribe to see more

$99M

Subscribe to see more

0

Date

9/6/2017

10/14/2010

Round

Series A - IV

Angel

Company

Orion Labs

Subscribe to see more

Amount

$10.5M

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

3

0

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.